Shareholders meeting

HEXAGON NUTRITION LIMITED 'Nutritionally Yours... Ref: HNL/SEC/2026-27/28 Date: 31st August 2026 National Stock Exchange of India Limited BSE Limited Listing & Compliance Department Listing Department Exchange Plaza, C-1, Block G, Floor 25, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001 Mumbai – 400051, Maharashtra, India. Maharashtra, India. SYMBOL: HEXAGON Scrip Code: 544785 Subject: Notice of 33rd Annual General Meeting (AGM’) and Annual Report of the Company for the Financial Year 2025-26 Dear Sir/ Madam, We wish to inform you that the 33rd Annual General Meeting (“AGM”) of the Company will be held on Tuesday, 22nd September 2026 at 11:30 A.M. (IST) through Video Conferencing/ Other Audio- Visual Means. Pursuant to Regulation 30, 34 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015, please find enclosed herewith the Notice of the 33rd AGM of Hexagon Nutrition Limited along with the Annual Report for the Financial Year 2025-26 which is being sent through electronic mode to the Members whose email addresses are registered with the Company/ Registrar & Share Transfer Agent/ Depository Participant(s). The Annual Report for the Financial Year 2025-26 along with the Notice of the 33rd AGM is also available on the website of the Company at https://hexagonnutrition.com/annual-report . This is for your information and records. Yours faithfully, For Hexagon Nutrition Limited Vedanti Vartak Company Secretary and Compliance Officer ICSI Membership No.: A41580 Encl: As below CIN:- L24110MH1993PLC072189 Nashlk Plant : Registered Office : Plot No. 92 & Plot No. 447, Unandanagar, Lakhamapur, 404 Global Chamber, Adarsh Nagar, Link Road, Dlndorl, Naslk - 422 202, Maharashtra, India Andherl (W), Mumbai, Maharashtra - 400053, India Tel. No,: +91-22-62136710/711 Chennal Plant: Webslte : www.hexagonnutrltlon.com Plot No. B11, Phase - 1 MEPZ-SEZ, Tambaram, Emall ID: enqulry@hexagonnutrltlon.com Chennal - 600 045, Tamll Nadu, Indla Creating Value Through Better Nutrition ANNUAL REPORT 2025-26 Our approach to value creation extends across the entire ecosystem. For customers, Contents we provide dependable nutrition solutions backed by technical expertise and consistent quality; for consumers and patients, Corporate Overview our products are designed to support 04 About Hexagon Nutrition better nutrition and quality of life; and for 06 Product Portfolio our stakeholders, we aim to build a resilient 10 Manufacturing Footprint and responsible business. Quality remains 11 Global Presence central to this approach, with a strong focus 12 Key Milestones on safety, consistency, process discipline and 14 Key Performance Indicators continuous improvement across 16 Chairman’s Message our operations. 18 Message from the Managing Director Creating 20 Message from the Joint Managing As the global nutrition landscape evolves, Director Value Through we remain focused on strengthening our 22 Research & Development capabilities, expanding our portfolio, 24 Our Business Model - A Fully Integrated Better Nutrition deepening customer relationships and Value Chain 26 Building the Next Phase of Growth pursuing opportunities across domestic and » · 28 Corporate Social Responsibility international markets. By bringing together & 30 Board of Directors scientific expertise, manufacturing excellence, 32 Management Team innovation and customer understanding, • we aim to create sustainable value while ~ca. 'i@@our contributing to a healthier future. Creating Statutory Reports we value through better nutrition is not only our 34 Corporate Information business opportunity; it is the purpose that 35 Notice continues to guide our growth. 55 Directors’ Report 76 Corporate Governance Report 100 Management Discussion & Analysis Nutrition is increasingly recognised as a 2025-26 highlights fundamental pillar of health, prevention, recovery and overall well-being. T Financial Statements 3,826 Million 108 Standalone At Hexagon Nutrition, we see this transformation As healthcare systems shift towards Revenue from operations 180 Consolidated as an opportunity to create meaningful value preventive approaches, consumers become through science, innovation and quality. more conscious of their nutritional choices, and governments and institutions place 529 Million 32% Our capabilities span micronutrient premixes, greater emphasis on nutritional security, therapeutic foods, clinical nutrition, food the demand for science-led nutrition EBITDA fortification and consumer nutrition, enabling solutions is expanding. From addressing us to address diverse nutritional needs across micronutrient deficiencies and supporting customers, applications and markets. Supported maternal and child health to enabling clinical 379 Million 56% by research and development, specialised recovery and everyday wellness, nutrition is manufacturing capabilities and deep technical Profit After Tax (PAT) becoming integral to the healthcare journey. expertise, we translate evolving nutritional requirements into reliable and relevant solutions. Y-o-Y growth AAnnnnuuaall RReeppoorrtt 22002255--2266 HHeexxaaggoonn NNuuttrriittiioonn LLiimmiitteedd Corporate Overview Statutory Reports Financial Statements IPO Listing 'NSE £NSE A Significant Milestone At a Glance Subscription Details 138.87 Crore 138.87 Crore IPO Size Total Issue Amount (Incl. Firm Reservations) 45 per share 19.77 118.15 Issue Price QIB (X) SNII (X) June 12, 2026 183.16 161.49 Listing Date BNII (X) NII (X) NSE & BSE 26.85 53.68 Listing Exchanges Retail (X) Total (X) Offer for Sale Issue Type 48.25 per share Our successful listing on the NSE and BSE on June 12, 2026 marked a significant milestone in our journey and a defining step in our evolution as a publicly listed Listing Price – NSE company. The IPO provided a strong platform to enhance our visibility, broaden our shareholder base and support the next phase of our growth. It reflects the T 48.00 per share confidence placed in our business model, capabilities and long-term Listing Price – BSE growth potential. 0022 03 Annual Report 2025-26 Hexagon Nutrition Limited Corporate Overview Statutory Reports Financial Statements Our diversified portfolio spans branded wellness and Vision clinical nutrition products (B2C), customised vitamin and To be a globally recognised, research-driven nutrition mineral premixes for leading domestic and multinational company — the partner of choice for individuals, FMCG companies (B2B2C), and therapeutic nutrition healthcare professionals, FMCG leaders, and solutions addressing malnutrition and public health humanitarian organizations seeking science-backed challenges through global institutional partnerships nutritional solutions. (ESG segment). Mission To improve human health and nutrition through innovative, Purpose affordable, and high-quality products across wellness, clinical nutrition, food fortification, and humanitarian Nourishing lives across geographies nutrition — delivered with consistency and care. — from FMCG fortification to fighting malnutrition — with science, integrity, Values and innovation. Customer Partnership Long-term relationships with FMCG majors, hospitals, and UN agencies. 55% repeat customers. Backed by strong scientific expertise and established Quality without Compromise I brands such as Pentasure, Obesigo and Pediagold, FSSC 22000, GMP, ISO 9001, Halal, Intertek/GAIN About Hexagon we have built a global presence across 75+ countries, certified across all plants. with regulatory approvals in more than 14 international markets. Our strategic partnerships with multinational Nutrition corporations, UN agencies and government bodies Science First further strengthen our capabilities and reach, creating Every product grounded in nutritional science and clinical high entry barriers and a strong competitive moat. evidence. DSIR approved R&D centres. € I [Showing first 8,000 characters — download PDF for full document]